Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Vaginitis × Clear all

Phase

Phase NA 3 Phase 2/3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 90 Neoplasms 89 Carcinoma, Non-Small-Cell Lung 67 Prostatic Neoplasms 62 Colorectal Neoplasms 62 Carcinoma, Hepatocellular 57 Leukemia, Myeloid, Acute 52 Stomach Neoplasms 45 Neoplasm Metastasis 45 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Lung Neoplasms 39 Pancreatic Neoplasms 34 Recurrence 31 Multiple Myeloma 27 Rectal Neoplasms 25 Colonic Neoplasms 25 Leukemia 24 Head and Neck Neoplasms 23 Ovarian Neoplasms 22 Lymphoma 21 Squamous Cell Carcinoma of Head and Neck 20 Hematologic Neoplasms 20 Myelodysplastic Syndromes 18 Esophageal Neoplasms 18 Urinary Bladder Neoplasms 17 Polycystic Ovary Syndrome 17 Lymphoma, Large B-Cell, Diffuse 16 Melanoma 15 Liver Neoplasms 15 Glioblastoma 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01420510 2013-06-21

Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis

Università degli Studi dell'Insubria

Phase 2/3 Unknown

Vaginitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡